Frequency analysis of atrial fibrillation from the surface electrocardiogram

Indian Pacing and Electrophysiology Journal

Volumn 4, Issue 3, 2004, Pages 122-136

  Husser, Daniela ^a,b   Stridh, Martin ^c   Sornmo, Leif ^c   Olsson, S Bertil ^c   Bollmann, Andreas ^a,b,c  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Antiarrhythmic drug monitoring; Atrial fibrillation; Cardioversion; ECG signal processing; Electrical remodeling

Indexed keywords

ANTIARRHYTHMIC AGENT; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CIBENZOLINE; FLECAINIDE; IBUTILIDE; MAGNESIUM; PROCAINAMIDE; SOTALOL; VERAPAMIL;

CARDIOVASCULAR PARAMETERS; CARDIOVERSION; CLINICAL PRACTICE; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIGITAL FILTERING; DRUG RESPONSE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FREQUENCY ANALYSIS; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART RATE; HUMAN; NON INVASIVE MEASUREMENT; POWER SPECTRUM; PREDICTION; QRS COMPLEX; RELIABILITY; REVIEW; SIGNAL PROCESSING; T WAVE;

EID: 17644368751     PISSN: 09726292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118-50.
2. Bollmann A. Quantification of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 2000;47:207-209.
3. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-68.
4. Kim KB, Rodefeld MD, Schuessler RB, et al. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation. 1996;94:2961-7.
5. Ramdat Misier AR, Opthof T, van Hemel NM, et al. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992;19:1531-5.
6. Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92:1193-202.
7. Konings KT, Kirchhof CJ, Smeets JR, et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation. 1994;89:1665-80.
8. Asano Y, Saito J, Matsumoto K, et al. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol. 1992;69:1033-8.
9. Boahene KA, Klein GJ, Yee R, et al. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol. 1990;16:1408-14.
10. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation. 1997;96:4298-306.
11. Fujiki A, Nagasawa H, Sakabe M, et al. Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J. 2001;65:1047-51.
12. Manios EG, Kanoupakis EM, Chlouverakis GI, et al. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. Cardiovasc Res. 2000;47:244-53.
13. Attuel P, Childers R, Cauchemez B, et al. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. Int J Cardiol. 1982;2:179-97.
14. Biffi M, Boriani G, Bartolotti M, et al. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart. 2002;87:443-448.
15. Holm M, Pehrson S, Ingemansson M, et al. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. Cardiovasc Res. 1998;38:69-81.
16. Bollmann A, Kanuru NK, McTeague KK, et al. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol. 1998;81:1439-45.
17. Rosenbaum DS, Cohen RJ. Frequency based measures of atrial fibrillation in man. IEEE-EMBS. 1990;12:582-3.
18. Slocum J, Sahakian A, Swiryn S. Diagnosis of atrial fibrillation from surface electrocardiograms based on computer-detected atrial activity. J Electrocardiol. 1992;25:1-8.
19. Bollmann A, Binias KH, Toepffer I, et al. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide. Am J Cardiol. 2002;90:1011-14.
20. Bollmann A, Husser D, Stridh M, et al. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making. J Cardiovasc Electrophysiol. 2003;14:S154-S161.
21. Bollmann A, Husser D, Steinert R, et al. Echo- and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol. 2003;14:S162-S165.
22. Bollmann A, Sonne K, Esperer HD, et al. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovasc Res. 1999;44:60-6.
23. Bollmann A, Sonne K, Esperer HD, et al. Circadian variations in atrial fibrillatory frequency in persistent human atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:1867-71.
24. Meurling CJ, Waktare JE, Holmqvist F, et al. Diurnal variations of the dominant cycle length of chronic atrial fibrillation. Am J Physiol Heart Circ Physiol. 2001;280:H401-6.
25. Waktare JE, Gallagher MM, Murtagh AM, et al. Optimum lead positioning for recording bipolar atrial electrocardiograms during sinus rhythm and atrial fibrillation. Clin Cardiol. 1998;21:825-30.
26. Stridh M, Sornmo L. Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation. IEEE Trans Biomed Eng. 2001;48:105-11.
27. Xi Q, Sahakian AV, Swiryn S. The effect of QRS cancellation on atrial fibrillatory wave signal characteristics in the surface electrocardiogram. J Electrocardiol. 2003;36:243-49.
28. Fujiki A, Sakabe M, Nishida K, et al. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation - spectral analysis of fibrillation waves from surface electrocardiogram. Circ J. 2003;67:391-395.
29. Fujiki A, Tsuneda T, Sugao M, et al. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol. 2003;92:472-475.
30. Pehrson S, Holm M, Meurling C, et al. Non-invasive assessment of magnitude and dispersion of atrial cycle length during chronic atrial fibrillation in man. Eur Heart J. 1998;19:1836-44.
31. Stridh M, Sornmo L, Meurling CJ, et al. Characterization of atrial fibrillation using the surface ECG: time-dependent spectral properties. IEEE Trans Biomed Eng. 2001;48:19-27.
32. Stridh M, Sornmo L, Meurling CJ, et al. Sequential characterization of atrial tachyarrhythmias based on ECG time-frequency analysis. IEEE Trans Biomed Eng. 2004;51:100-14.
33. Saoudi N, Cosio F, Waldo A, et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. Eur Heart J. 2001;22:1162 - 82.
34. Bollmann A, Husser D, Olsson SB. Atrial fibrillatory frequency, atrial fibrillatory rate or atrial cycle length - does it matter? Am J Cardiol. 2004;in press.
35. Holm M, Johansson R, Brandt J, et al. Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread - a hitherto unrecognised phenomenon in man. Eur Heart J. 1997;18:290-310.
36. Meurling CJ, Ingemansson MP, Roijer A, et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace. 1999;1:234-41.
37. Prystowsky EN, Naccarelli GV, Jackman WM, et al. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol. 1983;51:96-100.
38. Shimizu W, Tsuchioka Y, Karakawa S, et al. Differential effect of pharmacological autonomic blockade on some electrophysiological properties of the human ventricle and atrium. Br Heart J. 1994;71:34-7.
39. Leitch JW, Basta M, Fletcher PJ. Effect of phenylephrine infusion on atrial electrophysiological properties. Heart. 1997;78:166-70.
40. Cinca J, Moya A, Figueras J, et al. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. Am Heart J. 1986;112:315-21.
41. Huikuri HV, Yli-Mayry S, Linnaluoto MK, et al. Diurnal fluctuations in human ventricular and atrial refractoriness. Pacing Clin Electrophysiol. 1995;18:1362-8.
42. Bollmann A, Wodarz K, Esperer HD, et al. Response of atrial fibrillatory activity to carotid sinus massage in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2001;24:1363-8.
43. Ingemansson MP, Holm M, Olsson SB. Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation. Heart. 1998;80:71-6.
44. Stridh M, Meurling C, Olsson SB, et al. Detection of autonomic modulation in permanent atrial fibrillation. Med Biol Eng Comput. 2003;41:625-9.
45. Wijffels MC, Dorland R, Mast F, et al. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation. 2000;102:260-7.
46. Fynn SP, Todd DM, Hobbs WJC, et al. Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14:485-91.
47. Wang J, Bourne GW, Wang Z, et al. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation. 1993;88:1030-44.
48. Zarkin GA, Bala MV, Calingaert B, et al. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Am J Manag Care. 1997;3:1387-94.
49. Tieleman RG, Van Gelder IC, Crijns HJ, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol. 1998;31:167-73.
50. Lombardi F, Colombo A, Basilico B, et al. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol. 2001;37:157-62.
51. Everett 4th TH, Li H, Mangrum JM, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation. 2000;102:1454-1460.
52. Yu WC, Lee SH, Tai CT, et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res. 1999;42:470-6.
53. Sato T, Mitamura H, Kurita Y, et al. Recoevry of electrophysiological parameters after conversion of atrial fibrillation. Int J Cardiol. 2001;79:183-189.
54. Sra J, Biehl M, Blanck Z, et al. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. Pacing Clin Electrophysiol. 1998;21:1105-10.
55. Timmermans C, Rodriguez LM, Smeets JL, et al. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 1998;9:122-8.
56. Smeets JL, Allessie MA, Lammers WJ, et al. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res. 1986;58:96-108.
57. Bollmann A, Mende M, Neugebauer A, et al. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2002;25:1179-84.
58. Tai CT, Chen SA, Liu AS, et al. Spectral analysis of chronic atrial fibrillation and its relation to minimal defibrillation energy. Pacing Clin Electrophysiol. 2002;25:1747-51.
59. Meurling CJ. Atrial fibrillation. Modulation of the atrial fibrillatory frequency. A noninvasive approach. Thesis. Rahms i Lund Tryckeri AB. 2000.
60. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-33.
61. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-40.
62. Bollmann A, Sonne K, Esperer HD, et al. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG. Ann Noninvasive Electrocardiol. 2002;7:92-7.
63. Ingemansson MP, Smideberg B, Olsson SB. Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolongs the atrial cycle length in chronic atrial fibrillation. Europace. 2000;2:106-14.
64. Schwartz RA, Langberg JJ. Atrial electrophysiological effects of ibutilide infusion in humans. Pacing Clin Electrophysiol. 2000;23:832-6.